Slc13a5 | solute carrier family 13 (sodium-dependent citrate transporter), member 5
Physiological systems
19 / 24 physiological systems tested
6 Significantly impacted by the knock-out
Immune system Limbs/digits/tail Hematopoietic system Behavior/neurological Skeleton Cardiovascular system
13 No significant impact
5 Not tested
Data collections
Gene metrics:4Significant phenotypes
3Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
short tibia | 1 supporting dataset | Slc13a5tm1b(EUCOMM)Hmgu | homozygote | Early adult | 1.15x10-6 | ||
abnormal QT variability | 1 supporting dataset | Slc13a5tm1b(EUCOMM)Hmgu | homozygote | Early adult | 9.25x10-5 | ||
increased leukocyte cell number | 1 supporting dataset | Slc13a5tm1b(EUCOMM)Hmgu | homozygote | Early adult | 6.03x10-5 | ||
increased grip strength | 1 supporting dataset | Slc13a5tm1b(EUCOMM)Hmgu | homozygote | Early adult | 3.14x10-5 |
| | | | | | | | | |
External links
No external links available for Slc13a5.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Slc13a5tm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell mouse |
Slc13a5tm1b(EUCOMM)Hmgu | Reporter-tagged deletion allele (with selection cassette) | | mouse |
Slc13a5tm1e(EUCOMM)Hmgu | Targeted, non-conditional allele | | ES Cell |
Slc13a5tm40170(L1L2_st2) | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector |